Detecting endometrial cancer

Endometrial cancer occurs in the endometrium – the inner lining of a woman’s uterus – and is the most common cancer of the female reproductive organs, according to the American Cancer Society. 

The ACS estimates nearly 52,000 new cases of endometrial cancer will be diagnosed this year in the U.S. The majority of endometrial cancers are detected and treated early with good outcomes and statistics show there are more than 600,000 women who are survivors of endometrial cancer. 

Currently, there is no screening test to detect endometrial cancer early in women who are at average risk for the cancer and have no symptoms. The familiar Pap test is effective at detecting cervical cancer and, in rare cases, may reveal unusual cells associated with endometrial cancer, according to Dr. Troy Gatcliffe, a gynecologic oncologist affiliated with West Kendall Baptist Hospital, Baptist Hospital, South Miami Hospital and Doctors Hospital. 

Because there is no specific screening test, it’s important that women know the risk factors and symptoms of endometrial cancer and discuss this information and any changes in their bodies with their doctor. 

Risk factors 

Endometrial cancer occurs more frequently in Caucasian women over age 50. It is a hormone-driven cancer. After menopause, the ovaries stop making estrogen and progesterone, but a small amount of estrogen is still made naturally in fat tissue. This unopposed estrogen raises a woman’s risk for developing endometrial cancer. 

Greater cumulative estrogen exposure also is a risk factor, which means women who have never given birth, never were pregnant, began menstruation at an early age or began menopause later in life have a higher chance of developing endometrial cancer. 

Additional risk factors include high blood pressure, diabetes; endometrial hyperplasia – an abnormally high number of cells in the uterine lining; polycystic ovary syndrome – a hormonal disorder among women of reproductive age; hereditary nonpolyposis colon cancer (HNPCC, Lynch syndrome); history of benign endometrial growths; history of colon, breast or ovarian cancer; family history of uterine cancer; taking hormone replacement therapy, especially taking estrogen alone versus a combination of estrogen and progesterone; taking tamoxifen – a medication used to treat breast cancer; and being overweight. 

“Women with a BMI greater than 30 are especially at risk,” Dr. Gatcliffe said. “Maintaining a healthy weight through diet and exercise is the most important step women can take to lower their risk of endometrial cancer.” 

According to the National Cancer Institute, obese and overweight women have two-to-four times the risk of developing endometrial cancer than women of a normal weight, regardless of menopausal status. 


Abnormal vaginal bleeding is the most common symptom. Women may experience extremely long, heavy or frequent bleeding episodes or bleeding between periods or after menopause. 

Additional symptoms include lower abdominal or pelvic pain; a lump or a mass in the lower abdomen; difficulty or pain while urinating; pain during sexual intercourse; and unexplained weight loss. 

“Post-menopausal women should not experience any bleeding – not even for a day,” Dr. Gatcliffe said. “If they do, they should consult their doctor. Early detection improves treatment outcomes.” 


If you have symptoms of endometrial cancer, your doctor may review your medical history and family history of cancer; examine your abdomen for any abnormal masses or lumps; perform a pelvic examination and a Pap test; perform a blood test; order a CT scan, MRI or transvaginal ultrasound; perform an endometrial biopsy; or perform a dilation and curettage (D&C) surgery to remove the uterine lining to check for cancer or abnormal cells. 

Treatment options 

The four basic types of treatment for women with endometrial cancer are surgery, radiation therapy, hormonal therapy and chemotherapy. Your doctor will recommend one or more treatment options, taking into consideration the stage of the disease and other factors, such as your age, overall state of health and fertility goals. 

“Regardless of the treatment chosen, the key is early detection and that means paying attention to your body and reporting any unusual changes,” Dr. Gatcliffe says. 

Dr. Gatcliffe will be one of the speakers at the Cayman Islands Cancer Society’s Conquering Cancer three-day event, Sept. 17-19. 

Dr. Gatcliffe
Dr. Gatcliffe